PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...
Pfizer’s multiple myeloma drug Elrexfio met its main goal in a late-stage trial, delivering a statistically significant and clinically meaningful improvement in progression-free survival over standard ...
April 29 () - Pfizer said on Wednesday its drug Elrexfio met the main goal in a late-stage trial that tested the blood ...
Pfizer and Astellas have received the US Food and Drug Administration (FDA) acceptance for priority review of their ...
Pfizer (PFE) stock is in focus as a trial for the company's Elrexfio multiple myeloma drug hit the main goal with patients on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results